Levent Soyluoğlu

We sit down with Levent Soyluoğlu, CFO of TRPharm, to walk through the 360-degree corporate transformation of a rare-diseases pharmaceutical company — and how strategic planning was designed at every step. Levent began his career in audit, spent 5.5 years there, then moved to the İsfarma group where he held senior finance leadership roles in pharma for over a decade. He joined TRPharm — which began operating in Türkiye in 2013 — as CFO 18 months ago.

TRPharm started its growth journey with a 30-person team serving patients with rare diseases. Under Levent’s tenure, a 360-degree corporate transformation has positioned finance at the centre of strategic decision-making, given the planning discipline a real institutional backbone, and made it possible to capture growth opportunities with discipline rather than ad-hoc reaction.

The key to turning strategic planning into a sustainable platform, Levent argues, is to lift it out of the once-a-year spreadsheet exercise and embed it in the company’s daily decision-making. He walks through the specific steps, the tools and the time horizon used to make that shift.

The practical insights from a finance leader with an audit background, designing strategic planning inside a heavily regulated sector, are particularly useful. Which decisions belong to which step of the roadmap, and which leading indicators actually show whether the transformation is working — both questions get sharper answers in this conversation.

Throughout the episode the journey of finance — from a pure support function to a genuine part of the company’s strategic core — is illustrated with concrete examples. A useful case study on how the role of finance evolves inside a fast-scaling company.